These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 10867643)
1. The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors. Ferracini R; Scotlandi K; Cagliero E; Acquarone F; Olivero M; Wunder J; Baldini N J Cell Physiol; 2000 Aug; 184(2):191-6. PubMed ID: 10867643 [TBL] [Abstract][Full Text] [Related]
2. Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. Scotlandi K; Baldini N; Oliviero M; Di Renzo MF; Martano M; Serra M; Manara MC; Comoglio PM; Ferracini R Am J Pathol; 1996 Oct; 149(4):1209-19. PubMed ID: 8863670 [TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984 [TBL] [Abstract][Full Text] [Related]
4. Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas. Helou K; Wallenius V; Qiu Y; Ohman F; Ståhl F; Klinga-Levan K; Kindblom LG; Mandahl N; Jansson JO; Levan G Oncogene; 1999 May; 18(21):3226-34. PubMed ID: 10359528 [TBL] [Abstract][Full Text] [Related]
5. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827 [TBL] [Abstract][Full Text] [Related]
6. Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas. Choi JH; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Lim HW; Lee SW; Kang SM Acta Otolaryngol; 2006 Jul; 126(7):724-9. PubMed ID: 16803712 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Di Renzo MF; Olivero M; Ferro S; Prat M; Bongarzone I; Pilotti S; Belfiore A; Costantino A; Vigneri R; Pierotti MA Oncogene; 1992 Dec; 7(12):2549-53. PubMed ID: 1334253 [TBL] [Abstract][Full Text] [Related]
8. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors. Naim R; Tolnay E; Mueller KM; Kuhnen C Int J Mol Med; 2004 Nov; 14(5):787-91. PubMed ID: 15492846 [TBL] [Abstract][Full Text] [Related]
9. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Qian CN; Guo X; Cao B; Kort EJ; Lee CC; Chen J; Wang LM; Mai WY; Min HQ; Hong MH; Vande Woude GF; Resau JH; Teh BT Cancer Res; 2002 Jan; 62(2):589-96. PubMed ID: 11809714 [TBL] [Abstract][Full Text] [Related]
10. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398 [TBL] [Abstract][Full Text] [Related]
11. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro. Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703 [TBL] [Abstract][Full Text] [Related]
12. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps. Rho HS; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Park MK; Kang SM Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):985-9. PubMed ID: 16982975 [TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma. Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. Nakashiro K; Hayashi Y; Oyasu R Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672 [TBL] [Abstract][Full Text] [Related]
16. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271 [TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats. Shimamura M; Sato N; Sata M; Wakayama K; Ogihara T; Morishita R Brain Res; 2007 Jun; 1151():188-94. PubMed ID: 17425951 [TBL] [Abstract][Full Text] [Related]
18. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Kim CH; Kim J; Kahng H; Choi EC Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073 [TBL] [Abstract][Full Text] [Related]
19. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness. Hecht M; Schulte JH; Eggert A; Wilting J; Schweigerer L Carcinogenesis; 2005 Dec; 26(12):2105-15. PubMed ID: 16051641 [TBL] [Abstract][Full Text] [Related]
20. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells. To C; Seiden I; Liu N; Wigle D; Tsao MS Exp Cell Res; 2002 Feb; 273(1):45-53. PubMed ID: 11795945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]